Effect of GSK3α and/or GSK3β knockout using CRISPR/Cas9 approach on the survival of various lymphoma cell lines
| Lymphoma line . | Null-knockout clones/total clones screened . | ||
|---|---|---|---|
| GSK3α . | GSK3β . | GSK3α/β . | |
| OCI-LY1 | 9/17 | 19/24 | 6/13 |
| OCI-LY19 | 20/28 | 0/24 | nd |
| Jeko | 7/12 | 0/24 | nd |
| Mino | 5/12 | 0/36 | nd |
| Karpas299 | 12/20 | 0/26 | nd |
| Lymphoma line . | Null-knockout clones/total clones screened . | ||
|---|---|---|---|
| GSK3α . | GSK3β . | GSK3α/β . | |
| OCI-LY1 | 9/17 | 19/24 | 6/13 |
| OCI-LY19 | 20/28 | 0/24 | nd |
| Jeko | 7/12 | 0/24 | nd |
| Mino | 5/12 | 0/36 | nd |
| Karpas299 | 12/20 | 0/26 | nd |
nd, not done.